Responses of human fetal splenocytes and thymocytes to interleukin-2: Lak activity and proliferation

Ning Zhiqiang ,Chen Dezheng ,Wang Yuzhi 
DOI: https://doi.org/10.1007/BF02997230
1990-01-01
Chinese Journal of Cancer Research
Abstract:Using cytotoxicity and thymidine uptake assays, we investigated the effects of human recombinant interleukin-2 (rIL-2) on the induction of lympholine-activated killer (LAK) activity and cellular proliferation in splenocytes and thymocytes from human fetuses (18–22 weeks). We observed that fetal splenocytes and thymocytes incubated with low doses of rIL-2 (10–100 U/ml) developed broad antitumor activity (LAK activity) although the kinetics and magnitudes of the responses were different. It indicated the LAK precursors are present in fetal spleen and thymus. Further, rIL-2 induced a strong proliferative response in splenocytes, but not in thymocytes. On the basis of the findings, we conclude that the responses of fetal splenocytes and thymocytes to IL-2 are different.
What problem does this paper attempt to address?